Industry Insights

From Brian Armstrong to Vitalik Buterin, founders who helped build the crypto economy are now investing in longevity science. The overlap reveals a deeper connection: both movements attempt to preserve value across time - financial and biological.

More than $5B in longevity and biotech capital was raised globally between July and November 2025. From reprogramming therapeutics to preventive clinics, the sector is entering a pivotal consolidation phase. Here’s what the new funding wave means for longevity’s future.